Potent and selective proline derived dipeptidyl peptidase IV inhibitors

被引：49

作者：

Edmondson, SD

Mastracchio, A

Beconi, M

Colwell, LF

Habulihaz, B

He, HB

Kumar, SJ

Leiting, B

Lyons, KA

Mao, A

Marsilio, F

Patel, RA

Wu, JK

Zhu, L

Thornberry, NA

Weber, AE

Parmee, ER

机构：

[1] Merck & Co Inc, Dept Med Chem, Rahway, NJ 07065 USA

[2] Merck & Co Inc, Dept Drug Metab, Rahway, NJ 07065 USA

[3] Merck & Co Inc, Dept Metab Disorders, Rahway, NJ 07065 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2004年 / 14卷 / 20期

关键词：

dipeptidyl peptidase IV; selective; proline amide; thiazolidine; type; 2; diabetes;

D O I：

10.1016/j.bmcl.2004.07.056

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

In-house screening of the Merck sample collection identified proline derived homophenylalanine 3 as a DPP-IV inhibitor with modest potency (DPP-IV IC50 = 1.9 muM). Optimization of 3 led to compound 37, which is among the most potent and selective DPP-IV inhibitors discovered to date. (C) 2004 Elsevier Ltd. All rights reserved.

引用

页码：5151 / 5155

页数：5

共 50 条

[21] 4-Aminophenylalanine and 4-aminocyclohexylalanine derivatives as potent, selective, and orally bioavailable inhibitors of dipeptidyl peptidase IV
Duffy, Joseph L.
Kirk, Brian A.
Wang, Liping
Eiermann, George J.
He, Huaibing
Leiting, Barbara
Lyons, Kathryn A.
Patel, Reshma A.
Patel, Sangita B.
Petrov, Alexsandr
Scapin, Giovanna
Wu, Joseph K.
Thornberry, Nancy A.
Weber, Ann E.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (10) : 2879 - 2885
[22] Dipeptidyl peptidase IV inhibitors derived from a mangrove flora Rhizophora mucronata: An in silico approach
Gurudeeban, Selvaraj
Satyavani, Kaliyamurthi
Ramanathan, Thirugnansambandam
Ravikumar, Palanisamy
BANGLADESH JOURNAL OF PHARMACOLOGY, 2012, 7 (03) : 203 - 210
[23] Plant dipeptidyl peptidase-IV inhibitors as antidiabetic agents: a brief review
Turdu, Gulmira
Gao, Hongwei
Jiang, Yingying
Kabas, Madina
FUTURE MEDICINAL CHEMISTRY, 2018, 10 (10) : 1229 - 1239
[24] Type 2 diabetes - Therapy with dipeptidyl peptidase IV inhibitors
Demuth, HU
McIntosh, CHS
Pederson, RA
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2005, 1751 (01): : 33 - 44
[25] Controversy about the relative efficacy of dipeptidyl peptidase IV inhibitors
Scheen, A. J.
DIABETOLOGIA, 2012, 55 (10) : 2848 - 2849
[26] Novel pyrrolopyrimidine analogues as potent dipeptidyl peptidase IV inhibitors based on pharmacokinetic property-driven optimization
Xie, Hui
Zeng, Lili
Zeng, Shaogao
Lu, Xin
Zhang, Guicheng
Zhao, Xin
Cheng, Na
Tu, Zhengchao
Li, Zhiyuan
Xu, Hongjiang
Yang, Ling
Zhang, Xiquan
Huang, Min
Zhao, Junling
Hu, Wenhui
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 52 : 205 - 212
[27] From lead to preclinical candidate: Optimization of β-homophenylalanine based inhibitors of dipeptidyl peptidase IV
Nordhoff, Sonja
Lopez-Canet, Meritxell
Hoffmann-Enger, Barbara
Bulat, Stephan
Cerezo-Galvez, Silvia
Hill, Oliver
Rosenbaum, Claudia
Rummey, Christian
Thiemann, Meinolf
Matassa, Victor G.
Edwards, Paul J.
Feurer, Achim
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (16) : 4818 - 4823
[28] Applications of dipeptidyl peptidase IV inhibitors in diabetes mellitus
McIntosh, CHS
Demuth, HU
Kim, S
Pospisilik, JA
Pederson, RA
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2006, 38 (5-6) : 860 - 872
[29] Do Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Cause Heart Failure?
Clifton, Peter
CLINICAL THERAPEUTICS, 2014, 36 (12) : 2072 - 2079
[30] A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitors
Lu, I-Lin
Tsai, Keng-Chang
Chiang, Yi-Kun
Jiaang, Weir-Torn
Wu, Ssu-Hui
Mahindroo, Neeraj
Chien, Chia-Hui
Lee, Shiow-Ju
Chen, Xin
Chao, Yu-Sheng
Wu, Su-Ying
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (08) : 1603 - 1611

← 1 2 3 4 5 →